← Back to Patent Explorer
US4235875A Expired / Lapsed US ⏱️ 0.0 years remaining

Anticaries piperidino compounds

Assignee: Pharmacia Animal Health Inc
•
Filing: 1978-04-24
•
Granted: 1980-11-25
•
Expires: 1998-04-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel alkyl 1-(hydroxyalkyl)piperidines and acid addition salts thereof, useful as inhibitors of dental plaque and therefore also useful against dental caries and periodontitis, are disclosed. Methods of making same, orally-acceptable compositions thereof, a method of treating therewith, and important and novel intermediates for the production thereof are also disclosed.

Inventors

  • 👤 Sven E. H. Hernestam
  • 👤 Lars O. Willard
  • 👤 Aina L. Abramo
  • 👤 Hans-Bertil Johansson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 07:37
CPC Classifications
C; C07; C07D; C07D211/00; C07D211/04; C07D211/06; C07D211/08; C07D211/10; C07D211/14; A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/49; A61K8/4906; A61K8/4926; A61P; A61P1/00; A61P1/02; A61P29/00; A61Q; A61Q11/00

Claims Analysis

Total Claims: 46
Claim 1
Independent Claim 142 words
An oral and dental hygiene composition suitable for use in the inhibition of dental plaque comprising (a) an alkyl 1-hydroxyalkylpiperidine having the Formula I, ##STR32## which is substituted in the 2,3, or 4 position with ##STR33## wherein R 1 is an alkyl group, straight or branched, having at least seven carbon atoms, R 2 is hydrogen or an alkyl group, R 1 and R 2 together having 7-14 carbon atoms, and wherein R 3 is a hydroxyalkyl group of 2-6 carbon atoms, the sum of the carbon atoms in R 1 , R 2 , and R 3 being at least ten; "C" representing CH 2 except for the one carbon atom bearing the said R 1 R 2 substitution, or (b) an orally acceptable acid addition salt thereof, in an amount effective for said purpose, in association with an orally-acceptable carrier.
Claim 2
Dependent Claim 142 words
An oral and dental hygiene composition suitable for use in the inhibition of dental plaque comprising (a) an alkyl 1-hydroxyalkylpiperidine having the Formula I, ##STR32## which is substituted in the 2,3, or 4 position with ##STR33## wherein R 1 is an alkyl group, straight or branched, having at least seven carbon atoms, R 2 is hydrogen or an alkyl group, R 1 and R 2 together having 7-14 carbon atoms, and wherein R 3 is a hydroxyalkyl group of 2-6 carbon atoms, the sum of the carbon atoms in R 1 , R 2 , and R 3 being at least ten; "C" representing CH 2 except for the one carbon atom bearing the said R 1 R 2 substitution, or (b) an orally acceptable acid addition salt thereof, in an amount effective for said purpose, in association with an orally-acceptable carrier.
Claim 3
Dependent Claim 9 words
Composition of claim 1 wherein R 3 is omega-hydroxyalkyl.
Claim 4
Dependent Claim 26 words
Composition of claim 1 wherein the total number of carbon atoms in R 1 , R 2 , and R 3 is between ten and fifteen.
Claim 5
Dependent Claim 17 words
Composition of claim 1 wherein R 1 is selected from the group consisting n-octyl, n-nonyl, and n-decyl.
Claim 6
Dependent Claim 20 words
Composition of claim 1 wherein R 3 is selected from the group consisting of 2-hydroxyethyl, 3-hydroxypropyl, 4-hydroxybutyl, 5-hydroxypentyl, and 6-hydroxyhexyl.
Claim 7
Dependent Claim 14 words
Composition of claim 1 wherein R 1 is n-octyl and R 3 is 3-hydroxypropyl.
Claim 8
Dependent Claim 14 words
Composition of claim 1 wherein the active ingredient is a 4-n-octyl-1-(3-hydroxypropyl)piperidine acid addition salt.
Claim 9
Dependent Claim 13 words
Composition of claim 1 wherein R 1 and R 2 are both alkyl.
Claim 10
Dependent Claim 14 words
The composition of claim 1 wherein R 1 is a symmetrically branched octyl group.
Claim 11
Dependent Claim 12 words
The composition of claim 1 wherein R 2 is hydrogen or methyl.
Claim 12
Dependent Claim 16 words
The composition of claim 1 wherein R 1 is a n-nonyl and R 3 is 3-hydroxypropyl.
Claim 13
Dependent Claim 15 words
The composition of claim 1 wherein the active ingredient is 3-n-nonyl-1-(3-hydroxypropyl) piperidine acid addition salt.
Claim 14
Dependent Claim 13 words
The composition of claim 1 wherein the active ingredient is 3-n-nonyl-1-(3-hydroxypropyl) piperidine hydrochloride.
Claim 15
Dependent Claim 15 words
The composition of claim 1 wherein R 1 is 2,2-dipropylethyl and R 3 is 2-hydroxyethyl.
Claim 16
Dependent Claim 15 words
The composition of claim 1 wherein the active ingredient is 4-(2,2-dipropylethyl)-1-(2-hydroxyethyl) piperidine acid addition salt.
Claim 17
Dependent Claim 13 words
The composition of claim 1 wherein the active ingredient is 4-(2,2-dipropylethyl)-1-(2-hydroxyethyl) piperidine hydrochloride.
Claim 18
Dependent Claim 136 words
Method for the inhibition of dental plaque, comprising the step of contacting a tooth with (a) an alkyl 1-hydroxyalkylpiperidine having the Formula I, ##STR34## which is substituted in the 2, 3, or 4 position with ##STR35## wherein R 1 is an alkyl group, straight or branched, having at least seven carbon atoms, R 2 is hydrogen or an alkyl group, R 1 and R 2 together having 7-14 carbon atoms, and wherein R 3 is a hydroxyalkyl group of 2-6 carbon atoms, the sum of the carbon atoms in R 1 , R 2 , and R 3 being at least ten; "C" representing CH 2 except for the one carbon atom bearing the said R 1 R 2 substitution, or (b) an orally acceptable acid addition salt thereof, in an amount effective for said purpose.
Claim 19
Dependent Claim 136 words
Method for the inhibition of dental plaque, comprising the step of contacting a tooth with (a) an alkyl 1-hydroxyalkylpiperidine having the Formula I, ##STR34## which is substituted in the 2, 3, or 4 position with ##STR35## wherein R 1 is an alkyl group, straight or branched, having at least seven carbon atoms, R 2 is hydrogen or an alkyl group, R 1 and R 2 together having 7-14 carbon atoms, and wherein R 3 is a hydroxyalkyl group of 2-6 carbon atoms, the sum of the carbon atoms in R 1 , R 2 , and R 3 being at least ten; "C" representing CH 2 except for the one carbon atom bearing the said R 1 R 2 substitution, or (b) an orally acceptable acid addition salt thereof, in an amount effective for said purpose.
Claim 20
Dependent Claim 14 words
The method of claim 17, wherein R 1 is a symmetrically branched octyl group.
Claim 21
Dependent Claim 12 words
The method of claim 17 wherein R 2 is hydrogen or methyl.
Claim 22
Dependent Claim 15 words
The method of claim 17 wherein R 1 is n-nonyl and R 3 is 3-hydroxypropyl.
Claim 23
Dependent Claim 15 words
The method of claim 17 wherein the active ingredient is 3-n-nonyl-1-(3-hydroxypropyl) piperidine acid addition salt.
Claim 24
Dependent Claim 13 words
The method of claim 17 wherein the active ingredient is 3-n-nonyl-1-(3-hydroxypropyl) piperidine hydrochloride.
Claim 25
Dependent Claim 15 words
The method of claim 17 wherein R 1 is 2,2-dipropylethyl and R 3 is 2-hydroxyethyl.
Claim 26
Dependent Claim 15 words
The method of claim 17 wherein the active ingredient is 4-(2,2-dipropylethyl)-1-(2-hydroxyethyl) piperidine acid addition salt.
Claim 27
Dependent Claim 13 words
The method of claim 17 wherein the active ingredient is 4-(2,2-dipropylethyl)-1-(2-hydroxyethyl) piperidine hydrochloride.
Claim 28
Dependent Claim 10 words
The method of claim 17 wherein R 3 is omega-hydroxyalkyl.
Claim 29
Dependent Claim 27 words
The method of claim 17 wherein the total number of carbon atoms in R 1 , R 2 , and R 3 is between ten and fifteen.
Claim 30
Dependent Claim 19 words
The method in claim 17 wherein R 1 is selected from the group consisting of n-octyl, n-nonyl, and n-decyl.
Claim 31
Dependent Claim 21 words
The method of claim 17 wherein R 3 is selected from the group consisting of 2-hydroxyethyl, 3-hydroxypropyl, 4-hydroxybutyl, 5-hydroxypentyl, and 6-hydroxyhexyl.
Claim 32
Dependent Claim 15 words
The method of claim 17 where R 1 is n-octyl and R 3 is 3-hydroxypropyl.
Claim 33
Dependent Claim 15 words
The method of claim 17 wherein the active ingredient is a 4-n-octyl-1-(3-hydroxypropyl)piperidine acid addition salt.
Claim 34
Dependent Claim 14 words
The method of claim 17, wherein both R 1 and R 2 are alkyl.
Claim 35
Dependent Claim 50 words
A compound selected from the group consisting of (a) an alkyl 1-hydroxyalkyl piperidine having the formula B ##STR36## wherein R 1 is selected from the group consisting of 2,2-dipropylethyl and 2-ethyl-3-propylbutyl, R 2 is hydrogen, and R 3 is omega-hydroxyethyl or omega-hydroxypropyl, and (b) an orally-acceptable acid addition salt thereof.
Claim 36
Dependent Claim 50 words
A compound selected from the group consisting of (a) an alkyl 1-hydroxyalkyl piperidine having the formula B ##STR36## wherein R 1 is selected from the group consisting of 2,2-dipropylethyl and 2-ethyl-3-propylbutyl, R 2 is hydrogen, and R 3 is omega-hydroxyethyl or omega-hydroxypropyl, and (b) an orally-acceptable acid addition salt thereof.
Claim 37
Dependent Claim 10 words
The compound of claim 33 wherein R 1 is 2,2-dipropylethyl.
Claim 38
Dependent Claim 10 words
The compound of claim 33 wherein R 1 is 2-ethyl-3-propylbutyl.
Claim 39
Dependent Claim 10 words
The compound of claim 33 wherein R 3 is 2-hydroxyethyl.
Claim 40
Dependent Claim 10 words
The compound of claim 33 wherein R 3 is 3-hydroxypropyl.
Claim 41
Dependent Claim 12 words
The compound of claim 33 which is 4-(2,2-dipropylethyl)-1-(3-hydroxypropyl) piperidine acid addition salt.
Claim 42
Dependent Claim 12 words
The compound of claim 33 which is 4-(2,2-dipropylethyl)-1-(2-hydroxyethyl) piperidine acid addition salt.
Claim 43
Dependent Claim 9 words
The compound of claim 33 which is 4-(2,2-dipropylethyl)-1-(2-hydroxyethyl)piperidine hydrochloride.
Claim 44
Dependent Claim 12 words
The compound of claim 33 which is 4-(2-ethyl-3-propylbutyl)-1-(3-hydroxypropyl) piperidine acid addition salt.
Claim 45
Dependent Claim 9 words
The compound of claim 33 which is 4-(2,2-dipropylethyl)-1-(3-hydroxypropyl)piperidine hydrochloride.
Claim 46
Dependent Claim 9 words
The compound of claim 33 which is 4-(2-ethyl-3-propylbutyl)-1-(3-hydroxypropyl)piperidine hydrochloride.

References Cited (Backward Citations)

US2921886A Cited
US3322618A Cited
US3446808A Cited
US4144320A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-11-25 1984-05-26 1984-11-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-11-25 1988-05-26 1988-11-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-11-25 1992-05-26 1992-11-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag